Fed’s Powell opens door to potential rate cuts at Jackson Hole
In a remarkable display of market resilience, IBEX Holdings Ltd . stock has soared to a 52-week high, with shares trading at an impressive $22.45. According to InvestingPro analysis, the company appears undervalued with a "GREAT" financial health score of 3.38. This peak represents a significant milestone for the company, reflecting a robust 1-year return of 32.14%. Trading at an attractive P/E ratio of 11.48x, investors have shown growing confidence in IBEX's business model and future prospects, propelling the stock to new heights. The company's performance, particularly over the past year, underscores a strong recovery and a positive outlook that has caught the attention of both analysts and shareholders alike. InvestingPro subscribers can access 12 additional investment tips and a comprehensive Pro Research Report for deeper insights into IBEX's potential.
In other recent news, IBEX Ltd (NASDAQ:IBEX) has completed a $70 million share repurchase, solidifying its financial standing. The repurchase involved 3,562,341 common shares from The Resource Group International Limited (TRGI), paid in part with cash and a convertible promissory note. This transaction has resulted in a change in the company's ownership structure, ending its status as a "controlled company" under Nasdaq rules. The board now consists of a majority of independent directors.
The company's annual general meeting saw shareholders approve several key proposals, including setting the board of directors' size, electing directors, and appointing Deloitte & Touche LLP as the company's auditor for the upcoming fiscal year. The move has been seen as a commitment to shareholder value.
In terms of financial performance, IBEX Ltd started the fiscal year 2025 with record Q1 revenue of $129.7 million, a 4.1% increase from the previous year. Adjusted EBITDA rose to $15.6 million, while adjusted EPS saw a 30% increase to $0.52. Based on these results, the company has raised its full-year revenue guidance to between $515 million and $525 million, with adjusted EBITDA expected to reach $67 million to $69 million. These recent developments indicate a robust financial outlook for the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.